The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity. Borsche M, Pratuseviciute N, Schaake S, Hinrichs F, et al. Mov Disord 2023 Mar 27. doi: 10.1002/mds.29385.

Read + Share

Amedeo Smart

Independent Medical Education

Borsche M, Pratuseviciute N, Schaake S, Hinrichs F, et al. The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity. Mov Disord 2023 Mar 27. doi: 10.1002/mds.29385.
PMID: 36971062